logo
Shandong Huaxin Medical Device Co., Ltd.
Основные продукты:Гипербарическая Oxgyen камеры, мягкий, гипербарическая Oxgyen камеры, HBOT камеры, mhbot камеры, recompressure камеры
2YRSShandong Huaxin Medical Device Co., Ltd.

Обзор компании

Альбом компании

Основная информация
Huaxin Hyperbaric Oxygen Chamber Manufacture Company was established in 1988 with all relavant Licenses in the industry, and since the inception, we were becoming the leading manufacturer of all kinds of Hyperbaric Oxygen Chambers and Pressure Vessels in China.In the first decades, Huaxin acted as designated Manufacturer of Hyperbaric Oxygen Chambers for China pharmaceutical Administration, offering International Standard qualified Medical equipments to hundreds of Civil Hospitals around China mainland.In the following decades, Huaxin keeps the same faith on the quality controlling and absorbs more technical talents into our team. More and more advanced generations of HBOT systems are produced and promoted to domestic and international markets.Over 100 Well-skilled workers,16 R&D staffs,40 well-educated sales and after-sales service staffs, this elite team is to make sure that our equipments pretty qualified, our services pretty professional.For this purpose, Huaxin is learning all advanced relative technologies from domestic and aboard of China, and welcome all learned people to join us.On this road, Huaxin ever never stops.
  • Транзакции
    -
  • Время отклика
    ≤18h
  • Частота откликов
    37.5%
Тип компании
Производитель, Торговая компания
Страна / Регион
Shandong, China
Основные продуктыВсего сотрудников
11 - 50 People
Общий годовой доход
Below US$1 Million
Год основания
2021
Сертификаты
-
Сертификаты на продукцию
-
Патенты
-
Товарные знаки
-
Основные рынки

Емкость продукта

Информация о заводе

Размер завода
10,000-30,000 square meters
Местоположение завода
No.14009,Minzhu Street,Economic Development Zone,Weifang City,Shandong Province,China
Число производственных линий
Above 10
Контрактное производство
OEM Service Offered
Годовой выпуск
Above US$100 Million

R&D возможности

Исследования и разработки

31 - 40 People